Literature DB >> 8887083

The relationship between the adenine nucleotide metabolism and the conversion of the xanthine oxidase enzyme system in ischemia-reperfusion of the rat small intestine.

Y Hirata1, T Taguchi, M Nakao, T Yamada, R Hirose, S Suita.   

Abstract

The time course of the energy metabolism after reperfusion, the relationship between the conversion of xanthine dehydrogenase to xanthine oxidase (D-to-O conversion) during ischemia, and the changes of the energy metabolism after reperfusion were studied using an ischemia-reperfusion model in the small intestine of the rat. The rat jejunum underwent an occlusion of the superior mesenteric artery and vein for either 30 minutes (group 1, n = 6) or 90 minutes (group 2, n = 6) with collateral interruption, and then it was reperfused. The contents of the adenine nucleotides in the small intestine of the rat were measured by high-performance liquid chromatography (HPLC) before ischemia, and 30, 60, and 90 minutes of ischemia, as well as 30, 60, 120, and 180 minutes after reperfusion. The recovery level of adenosine triphosphate (ATP) in group 1 (6.05 +/- 0.80 mumol/g dry weight) 30 minutes after reperfusion was significantly higher than that in group 2 (2.28 +/- 1.12 mumol/g dry weight) (P < .001). In addition, the ATP content after reperfusion in group 2 did not change from 30 to 180 minutes after reperfusion. The D-to-O conversion during ischemia in group 1 was not significantly greater than that before ischemia; however, that of group 2 did increase significantly during ischemia (P < .005). These results suggest that the tissue damage from ischemia-reperfusion injury after reperfusion under 90 minutes' ischemia is accomplished within the first 30 minutes after reperfusion. Therefore, the ATP level at 30 minutes after reperfusion may be useful for the evaluation of intestinal viability. Thus, the conversion of the xanthine oxidase enzyme system might play an important role in the expression of ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8887083     DOI: 10.1016/s0022-3468(96)90231-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  6 in total

1.  Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/ reoxygenation induced intestinal injury in newborn rats.

Authors:  Unal Biçakçi; Burak Tander; Ender Aritürk; Birsen Kiliçoğlu Aydin; Oğuz Aydin; Riza Rizalar; Zafer Eren; Ferit Bernay
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

2.  Mibefradil, a T-type Ca2+ channel blocker, protects against mesenteric ischemia-reperfusion-induced oxidative injury and histologic alterations in intestinal mucosa in rats.

Authors:  Hayrettin Ozturk; Hulya Ozturk; Hatun Duran; Ali Kemal Uzunlar
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

3.  Protective effects of vitamin E and omeprazole on the hypoxia/reoxygenation induced intestinal injury in newborn rats.

Authors:  Faysal O Cadir; Unal Bicakci; Burak Tander; Birsen Kilicoglu-Aydin; Riza Rizalar; Ender Ariturk; Oguz Aydin; Ferit Bernay
Journal:  Pediatr Surg Int       Date:  2008-04-22       Impact factor: 1.827

4.  Effects of trapidil on intestinal mucosal barrier function and bacterial translocation after intestinal ischemia and reperfusion in an experimental rat model.

Authors:  Tahsin Colak; Candan Ozturk; Ayse Polat; Ozlen Bagdatoglu; Arzu Kanik; Ozgur Turkmenoglu; Suha Aydin
Journal:  Curr Ther Res Clin Exp       Date:  2003-06

5.  Lifor Solution: An Alternative Preservation Solution in Small Bowel Transplantation.

Authors:  Mingxiao Guo; Chunlei Lu; Ying Gao; Haifeng Zhang; Dongfeng Chen; Yousheng Li
Journal:  Gastroenterol Res Pract       Date:  2016-01-12       Impact factor: 2.260

6.  Methylene Blue Attenuates Lung Injury Induced by Hindlimb Ischemia Reperfusion in Rats.

Authors:  Liangrong Wang; Baihui Chen; Bi Lin; Yuzhu Ye; Caiying Bao; Xiyue Zhao; Lida Jin; Xiangqing Xiong
Journal:  Mediators Inflamm       Date:  2018-03-11       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.